A boardroom reshuffle at pharmaceutical business
long-serving CFO Angus Russell appointed as chief executive.
Russell, who took the CFO role in 1999, takes on the top job in place of
Matthew Emmens – who moves to chairman.
He has served in the pharmaceutical industry for 27 years including his time
as Shire CFO, with roles at ICI, Zeneca and its successor business AstraZeneca.
Shire said it had met with corporate governance recommendations in the
combined Code in terms of appointing the former chief executive as chairman, by
consulting on the issue with shareholders.
‘As required by the UK Combined Code on Corporate Governance, these
appointments have been discussed in advance with major shareholders and
representatives of a shareholder representative body,’ the company said in a
Former chairman Dr James Cavanaugh has retired.
Pharmaceutical firm revamps
intranet to improve data access
Harrison Beale & Owen will (HB&O) have a new chairman and managing director at the helm for 2017
Satvir Bungar promoted to managing director in the mergers and acquisitions team
Carolyn Brown appointed as the first head of client legal services practice RSM Legal
UK senior partner Phil Verity has been elected for a second term at Mazars